346 related articles for article (PubMed ID: 4302180)
21. [Radioimmunoassay of ACTH].
Yuji S; Nakajima T; Watanabe A
Nihon Naibunpi Gakkai Zasshi; 1971 May; 47(2):110-4. PubMed ID: 4325459
[No Abstract] [Full Text] [Related]
22. Nyctohemeral variation and suppressibility of plasma ACTH in various stages of Cushing's disease.
Cook DM; Kendall JW; Allen JP; Lagerquist LG
Clin Endocrinol (Oxf); 1976 Jul; 5(4):303-12. PubMed ID: 183922
[TBL] [Abstract][Full Text] [Related]
23. [Study of plasma ACTH in 100 human lysine-vasopressin tests].
Binoux M; Gourmelen-Combourieu M; Luton JP; Girard F; Pham-Huu-Trung MT
Acta Endocrinol (Copenh); 1971 Sep; 68(1):1-30. PubMed ID: 4328565
[No Abstract] [Full Text] [Related]
24. A sensitive bioassay for the determination of human plasma ACTH levels.
Liotta A; Krieger DT
J Clin Endocrinol Metab; 1975 Feb; 40(2):268-7. PubMed ID: 165419
[TBL] [Abstract][Full Text] [Related]
25. Plasma ACTH in diagnosis and control of adrenal disorders.
Girard J; Eberle AN; Baumann JB
Acta Endocrinol Suppl (Copenh); 1986; 279():254-8. PubMed ID: 3022521
[TBL] [Abstract][Full Text] [Related]
26. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
27. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
28. Cushing's syndrome presenting the coexistence of a pituitary corticotrophic cell hyperplasia and a unilateral functional adrenal adenoma.
Watanobe H; Kawagishi T; Hirai Y; Sato T; Tsutsui M; Kamata Y; Takebe K
Acta Endocrinol (Copenh); 1985 Nov; 110(3):302-7. PubMed ID: 3000119
[TBL] [Abstract][Full Text] [Related]
29. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli.
Orth DN; Peterson ME; Drucker WD
Endocrinology; 1988 Apr; 122(4):1250-62. PubMed ID: 3126032
[TBL] [Abstract][Full Text] [Related]
30. Plasma pregnenolone and 17-OH-pregnenolone in patients with adrenal tumors, ACTH excess, or idiopathic hirsutism.
McKenna TJ; Miller RB; Liddle GW
J Clin Endocrinol Metab; 1977 Feb; 44(2):231-6. PubMed ID: 190251
[TBL] [Abstract][Full Text] [Related]
31. Cushing's syndrome due to huge nodular adrenocortical hyperplasia with fluctuation of urinary 17-OHCS excretion.
Makino S; Hashimoto K; Sugiyama M; Hirasawa R; Takao T; Ota Z; Saegusa M; Ohashi T; Omori H
Endocrinol Jpn; 1989 Oct; 36(5):655-63. PubMed ID: 2620663
[TBL] [Abstract][Full Text] [Related]
32. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
[TBL] [Abstract][Full Text] [Related]
33. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T
J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
[TBL] [Abstract][Full Text] [Related]
34. [Behavior of adrenocorticotropic internal secretions in Cushing's syndrome].
Silvestrini F; D'Alonzo R
Schweiz Med Wochenschr; 1970 Oct; 100(40):1680-4. PubMed ID: 4335210
[No Abstract] [Full Text] [Related]
35. Specific radioimmunoassay of human beta-endorphin in unextracted plasma.
Wiedemann E; Saito T; Linfoot JA; Li CH
J Clin Endocrinol Metab; 1979 Sep; 49(3):478-80. PubMed ID: 468983
[TBL] [Abstract][Full Text] [Related]
36. Adrenal reserve function after unilateral adrenalectomy in patients with primary aldosteronism.
Honda K; Sone M; Tamura N; Sonoyama T; Taura D; Kojima K; Fukuda Y; Tanaka S; Yasuno S; Fujii T; Kinoshita H; Ariyasu H; Kanamoto N; Miura M; Yasoda A; Arai H; Ueshima K; Nakao K
J Hypertens; 2013 Oct; 31(10):2010-7. PubMed ID: 23846863
[TBL] [Abstract][Full Text] [Related]
37. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
Watanobe H; Tamura T
J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
[TBL] [Abstract][Full Text] [Related]
38. Cortisol-suppressible dexamethasone-nonsuppressible cyclic Cushing's disease with evidence of clinical and biochemical remission with bromocriptine.
Mercado-Asis LB; Murayama M; Yamakita N; Morita H; Mune T; Yasuda K; Miura K
Endocrinol Jpn; 1991 Jun; 38(3):315-24. PubMed ID: 1665413
[TBL] [Abstract][Full Text] [Related]
39. Adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia: an unusual cause of Cushing's syndrome.
Malchoff CD; Rosa J; DeBold CR; Kozol RA; Ramsby GR; Page DL; Malchoff DM; Orth DN
J Clin Endocrinol Metab; 1989 Apr; 68(4):855-60. PubMed ID: 2537845
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
